Cyclin D1 is a component of the core cell cycle machinery 1 . Abnormally high levels of cyclin D1 are detected in many human cancer types 2 . To elucidate the molecular functions of cyclin D1 in human cancers, we performed a proteomic screen for cyclin D1 protein partners in several types of human tumours. Analyses of cyclin D1 interactors revealed a network of DNA repair proteins, including RAD51, a recombinase that drives the homologous recombination process 3 . We found that cyclin D1 directly binds RAD51, and that cyclin D1-RAD51 interaction is induced by radiation. Like RAD51, cyclin D1 is recruited to DNA damage sites in a BRCA2-dependent fashion. Reduction of cyclin D1 levels in human cancer cells impaired recruitment of RAD51 to damaged DNA, impeded the homologous recombination-mediated DNA repair, and increased sensitivity of cells to radiation in vitro and in vivo. This effect was seen in cancer cells lacking the retinoblastoma protein, which do not require D-cyclins for proliferation 4, 5 . These findings reveal an unexpected function of a core cell cycle protein in DNA repair and suggest that targeting cyclin D1 may be beneficial also in retinoblastoma-negative cancers which are currently thought to be unaffected by cyclin D1 inhibition.
Cyclin D1 is a component of the core cell cycle machinery 1 . Abnormally high levels of cyclin D1 are detected in many human cancer types 2 . To elucidate the molecular functions of cyclin D1 in human cancers, we performed a proteomic screen for cyclin D1 protein partners in several types of human tumours. Analyses of cyclin D1 interactors revealed a network of DNA repair proteins, including RAD51, a recombinase that drives the homologous recombination process 3 . We found that cyclin D1 directly binds RAD51, and that cyclin D1-RAD51 interaction is induced by radiation. Like RAD51, cyclin D1 is recruited to DNA damage sites in a BRCA2-dependent fashion. Reduction of cyclin D1 levels in human cancer cells impaired recruitment of RAD51 to damaged DNA, impeded the homologous recombination-mediated DNA repair, and increased sensitivity of cells to radiation in vitro and in vivo. This effect was seen in cancer cells lacking the retinoblastoma protein, which do not require D-cyclins for proliferation 4, 5 . These findings reveal an unexpected function of a core cell cycle protein in DNA repair and suggest that targeting cyclin D1 may be beneficial also in retinoblastoma-negative cancers which are currently thought to be unaffected by cyclin D1 inhibition.
To elucidate the molecular functions of cyclin D1 in human cancer cells, we set out to identify cyclin D1-interacting proteins in four types of human tumours: mantle cell lymphoma (Granta 519 cells), breast cancer (MCF7 and ZR-75-1), squamous cell carcinoma (UMSCC-2), and colorectal cancer (HT-29). These cell lines overexpress cyclin D1 due to amplification or rearrangements within the cyclin D1 gene (CCND1), or due to mutations within the cyclin D1 degradation machinery [6] [7] [8] [9] . Cyclin D1-containing complexes were purified using double immunoaffinity purification 10 ( Supplementary Fig. 1 ), and the identity of cyclin D1 interactors was determined by repeated rounds of liquid chromatography and high-throughput mass spectrometry (LC-MS/MS). A total of 132 proteins were identified with high confidence (Fig. 1a, Supplementary Fig. 2 and Supplementary Tables 1-5 ).
We constructed a biological process/molecular function enrichment heat map of cyclin D1 interactors (Fig. 1b and Supplementary Table 6) , and searched for functions enriched in all four tumour types. Unexpectedly, apart from cell cycle control proteins, we observed the DNA repair category amongst the most enriched functions (Fig. 1b, Supplementary Fig. 3a and Supplementary Table 6 ). Using published databases of physical and functional interactions, we constructed a protein interaction network of all cyclin D1 interactors encountered by us in the five cell lines, and observed a cluster of DNA repair proteins centred on RAD51, a key DNA recombinase mediating DNA repair via homologous recombination 3 (Supplementary Fig. 3b ). These observations suggested that cyclin D1 may play a role in DNA damage repair.
Consistent with this possibility, we found that depletion of cyclin D1 by short hairpin RNA (shRNA) in cervical carcinoma HeLa cells and lung cancer H2009 cells, significantly increased the sensitivity of cancer cells to ionizing radiation ( Fig. 2a and Supplementary Fig. 4a, c) . We used these two retinoblastoma protein (pRB)-negative cell lines to rule out cell cycle effects of cyclin D1 knockdown, as pRB-negative cancer cells do not require D-cyclins for proliferation 4, 5 ( Supplementary Fig. 5 ). Reduction of cyclin D1 levels also sensitized cancer cells to DNAdamaging drugs camptothecin and etoposide ( , had no effect on sensitivity of cancer cells to ionizing radiation ( Supplementary Fig. 4b ). Moreover, expression of cyclin D1(K112E) point-mutant, which is unable to activate the CDKs 13, 14 , restored radiation susceptibility in cyclin D-null mouse embryonic fibroblasts (Supplementary Fig. 6 ). Collectively, these observations indicated that cyclin D1 might have a kinase-independent function in DNA repair.
We used comet assay 15 to directly assess the efficiency of DNA repair in cyclin D1-depleted human cancer cells. We found that radiation induced comparable levels of DNA damage in control and in cyclin D1-depleted cells (4-h time-point in Fig. 2c and in Supplementary Fig. 7a) . However, at 16 h post-radiation, more unrepaired DNA persisted in cyclin D1-depleted cells ( Fig. 2c and Supplementary  Fig. 7 ). We verified that this impaired rate of DNA repair was not a result of grossly compromised DNA damage-induced signalling ( Supplementary Fig. 8a, b) .
Because among cyclin D1 interactors we observed a network of DNA repair proteins including RAD51, a key DNA recombinase that drives the homologous recombination process 3, 16 ( Supplementary Fig.  3b ), we investigated a possible functional connection between cyclin D1 and homologous recombination-dependent DNA repair. Using a homologous recombination repair reporter, the DR-GFP system 17 , we found that depletion of cyclin D1 in HeLa and H2009 cells significantly reduced the homologous recombination rate ( Fig. 2d and Supplementary Fig. 9 ). As expected, re-expression of small interfering RNA (siRNA)-resistant cyclin D1 rescued this effect ( Supplementary  Fig. 10a-c) . These results indicated that cyclin D1 is required for an efficient homologous recombination DNA repair process. Consistent with this notion, cyclin D1 depletion sensitized cancer cells to treatment with poly (ADP-ribose) polymerase (PARP) inhibitor (Fig. 2e ), in concordance with the reports that deficiency in homologous recombination renders cells hypersensitive to these agents 18 .
To investigate the function of cyclin D1 in homologous recombination, we focused on cyclin D1 interaction with RAD51, detected in our screen. We established that cyclin D1 binds directly to RAD51 using purified, recombinant proteins, and that the amino terminus of cyclin D1 and the carboxy terminus of RAD51 mediate the interaction ( Fig. 3a and Supplementary Fig. 11 ). Expression of a cyclin D1 mutant which is deficient in RAD51 binding failed to restore normal homologous recombination rate in cyclin D1-depleted cells ( Supplementary  Fig. 10d ). We also verified physical binding of the endogenous cyclin D1 and RAD51 proteins in several human cancer cell lines ( Fig. 3b and Supplementary Fig. 12a ). The interaction between cyclin D1 and RAD51 was induced by radiation and it intensified with the increased ionizing radiation dose (Fig. 3c , upper panel, and Supplementary Fig.  12b , c). As reported, radiation resulted in a decrease of total levels of cyclin D1, without major changes in RAD51 levels 19, 20 ( Fig. 3c , lower panel, and Supplementary Fig. 12c , lower panel). The strong induction of cyclin D1-RAD51 interaction after radiation, in the face of reduced total cyclin D1 levels, suggests that an increased number of remaining cyclin D1 molecules is recruited to RAD51 complex to facilitate the DNA repair process. In pRB-positive cancer cells, decrease of total cyclin D1 levels upon radiation contributes to cell cycle arrest of these cells 19 . Conversely, forced overexpression of cyclin D1 may overcome cell cycle checkpoints, and may lead to radio-resistant DNA synthesis and apoptosis 20, 21 . Our results demonstrate that after radiation the remaining pool of cyclin D1 has a positive role in DNA repair. 
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To test whether cyclin D1 is recruited to the sites of damaged DNA, where RAD51 localizes after radiation, we used a system in which a unique I-SceI recognition site has been integrated into the genome of HeLa cells 17 . Using this system, one can monitor recruitment of repair proteins to the site of DNA damage using targeted chromatin immunoprecipitation (ChIP), followed by PCR with primers adjacent to DNA damage site [22] [23] [24] . As expected, we observed recruitment of RAD51 to the DNA damage site (Fig. 3d , left panel and Supplementary Fig. 13a, left panel, d) . Importantly, targeted anti-cyclin D1 ChIP showed that cyclin D1 was also recruited to the site of DNA damage ( Fig. 3e and Supplementary Fig. 13f) ; this recruitment disappeared once cyclin D1 had been knocked down ( Supplementary Fig.  13b, g ). Moreover, ChIP of cyclin D1 followed by re-ChIP with anti-RAD51 antibody indicated that cyclin D1 and RAD51 colocalize on the sites of double-stranded DNA breaks ( Fig. 3f and Supplementary  Fig. 13c ). Cyclin D1 recruitment to the damaged DNA was also detected by co-immunofluorescent staining with c-H2AX at laserinduced DNA damage stripes (Supplementary Fig. 14) .
To investigate how cyclin D1 facilitates the homologous recombination process, we studied recruitment of RAD51 to damaged DNA, a step that is required for RAD51 to perform its DNA recombinase function 25 . We found that knockdown of cyclin D1 reduced recruitment of RAD51 to I-SceI-induced DNA breaks (Fig. 3d , right panel and Supplementary Fig. 13a, right panel, e) , to laser-induced DNAdamage stripes ( Supplementary Fig. 15 ), and to radiation-induced DNA damage foci (Fig. 3g and Supplementary Figs 16 and 17) . We verified that the overall levels of RAD51 and of several other DNA damage response proteins were not affected by cyclin D1 knockdown ( Supplementary Fig. 8c ). Collectively, these findings suggest that cyclin D1 helps to recruit RAD51 to DNA damage sites through a direct cyclin D1-RAD51 physical interaction.
We next asked how cyclin D1 is recruited to sites of DNA damage. Among cyclin D1 interactors we observed BRCA2 (Fig. 1a , Supplementary Fig. 3 and Supplementary Tables 1-5 ), an essential homologous recombination protein which is recruited to DNA damage sites prior to RAD51 (ref. 25) . Using purified recombinant cyclin D1 protein and BRCA2 protein fragments 26 , we established that cyclin D1 interacts directly with BRCA2 (Fig. 3h) , and we verified physical interaction of the endogenous proteins (Fig. 3i) . Importantly, we found that knockdown of BRCA2 reduced recruitment of cyclin D1 to DNA damage sites (Fig. 3j, Supplementary Fig. 18a ). Depletion of cyclin D1 had no observable effect on BRCA2 recruitment ( Supplementary  Fig. 19a) , consistent with the notion that BRCA2 acts upstream of cyclin D1. Likewise, depletion of cyclin D1 had no detectable impact on other upstream events, such as DNA end-resection ( Supplementary  Fig. 20a-d) and loading of a single-stranded DNA binding protein RPA34 ( Supplementary Fig. 20e, f) . In contrast, depletion of cyclin D1 inhibited downstream events, namely recruitment of RAD51, and led to decreased co-localization of RAD51 and BRCA2 at DNA damage sites (Supplementary Fig. 18b) .
Collectively, these results are consistent with the model that cyclin D1 is recruited to DNA damage sites through BRCA2; cyclin D1 then helps to recruit RAD51 through a direct cyclin D1-RAD51 interaction. Depletion of cyclin D1 reduces RAD51 recruitment and reduces RAD51-BRCA2 co-localization at DNA damage sites, leading to impaired homologous recombination rate. Of note, a recent report ChIP. Bars show enrichment around DNA damage site. f, Co-localization of cyclin D1 and RAD51 at the DNA damage site. Anti-cyclin D1 ChIP was followed by anti-RAD51 re-ChIP and PCR with primers adjacent to doublestranded DNA break. g, Reduction of RAD51 recruitment to DNA damage foci in HeLa cells depleted of cyclin D1 (siD1-A, -C). Shown is percentage of cells with a given number of RAD51 foci per nucleus before (0 h) and 8 h after irradiation. h, In vitro binding assays using the indicated GST-BRCA2 fragments 26 and recombinant cyclin D1. Cyclin D1 was detected by anti-cyclin D1 immunoblotting. Amounts of input GST-BRCA2 fragments were verified by Ponceau staining (lower panel). i, Interaction between endogenous cyclin D1 and BRCA2 (B2) in H2009 cells, detected by immunoprecipitationimmunoblotting. j, Recruitment of cyclin D1 to an I-SceI-induced doublestranded DNA break, tested as in e, using cells transfected with independent anti-BRCA2 siRNAs (siBRCA2-A or siBRCA2-B), or with control siRNA (sicont). Bars show enrichment around DNA damage site. IP, immunoprecipitation; WCL, whole cell lysate; *P # 0.05; **P # 0.01; ***P # 0.005; error bars, standard deviation; n 5 3-5.
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indicated that cyclin D1 has a role in DNA damage response and that forced targeting of cyclin D1 to chromatin resulted in increased corecruitment of RAD51 upon DNA damage 27 . We verified that cyclin D1 is not required for recruitment of other DNA damage proteins detected as cyclin D1 interactors in our screen such as FANCD2, FANCI, PCNA and MSH6, as well as BRCA1 and MRE11 (Supplementary Figs 19, 21) . We also found that depletion of cyclin D1 has no detectable impact on DNA mismatch repair rate ( Supplementary Fig. 22 ).
Our observations suggested that depletion of cyclin D1 could sensitize human cancers to radiation, by limiting DNA repair. To test this, we knocked down cyclin D1 in three pRB-negative cancer cell lines: H2009, HeLa and in prostate cancer DU145. Cells were then injected subcutaneously into nude mice, which resulted in formation of tumours. As expected, depletion of cyclin D1 did not affect proliferation of cancer cells in vitro (Supplementary Figs 5c, d , 23a-c and 24a-c), and had no impact on the rate of tumour growth in vivo (Fig. 4a , b left panels and Supplementary Figs 24d-g left panels, and Supplementary Fig. 25a ). In contrast, upon irradiation, cyclin D1-depleted tumours had retarded growth compared to control tumours, revealing increased sensitivity to ionizing radiation (Fig. 4a, b , middle and right panels, and Supplementary Figs 23d, e, 24d-g middle and right panels, 25b-e and 26-28, and data not shown). Hence, whereas cyclin D1 is dispensable for proliferation of pRB-negative tumour cells, it has an important role in DNA repair, which becomes evident once cells undergo DNA damage.
The cyclin D1 gene corresponds to the second most frequently amplified region within the human cancer genome 28 . Our proteomic screen revealed that cyclin D1 has a function in human cancer cells in DNA repair through homologous recombination. Thus, targeting cyclin D1 in combination with radiation treatment may have potential therapeutic value in a large pool of pRB-negative cancers.
METHODS SUMMARY
Affinity immunopurification and mass spectrometry were as described 29 . Comet assays were performed according to manufacturer's protocol (Trevigen). RAD51 and cyclin D1 ChIP were performed using anti-RAD51 (H-92) or anti-cyclin D1
antibody (H-295, Santa Cruz). For ChIP-re-ChIP, haemagglutinin-tagged cyclin D1 was ChIP with anti-haemagglutinin antibody (12CA5, Covance), eluted with haemagglutinin peptide, and re-ChIP with anti-RAD51 antibody. Glutathione-Stransferase-tagged proteins were based on pGEX-5x-3 (GE Healthcare). Cancer cells used for in vivo tumour study were transduced with lentiviruses expressing anti-cyclin D1 or control shRNAs. Tumour cells (10 7 ) were injected subcutaneously into nu/nu mice. Tumours were target-irradiated using 137 Cs as a source. Tumour size was assessed on indicated days, and tumours were weighed at the end of the experiments. Statistical significance of the differences was evaluated using paired two-tailed Student's t-test. LETTER RESEARCH
